From Evidence-Based Medicine to Practice in Specific Grass Pollen Immunotherapy of Seasonal Allergic Rhinoconjunctivitis

被引:1
|
作者
Calderon, M. [1 ]
Moesges, R. [2 ]
Hellmich, M. [2 ]
Demoly, P. [3 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, London, England
[2] Univ Cologne, Cologne, Germany
[3] Univ Montpellier, Med Ctr, F-34059 Montpellier, France
关键词
D O I
10.1016/j.jaci.2009.12.484
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:AB123 / AB123
页数:1
相关论文
共 50 条
  • [21] Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma
    Roberts, G
    Hurley, C
    Turcanu, V
    Lack, G
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : 263 - 268
  • [22] From Evidence-Based Medicine to Evidence-Based Practice
    Meyer, Michelle N.
    HASTINGS CENTER REPORT, 2013, 43 (02) : 11 - 12
  • [23] Cross-reactivity and allergic rhinoconjunctivitis: Practical implications for immunotherapy with a timothy grass pollen tablet
    Demoly, P.
    Jeanniard, G. B.
    REVUE FRANCAISE D ALLERGOLOGIE, 2012, 52 (05): : 388 - 396
  • [24] Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis
    Wahn, Ulrich
    Tabar, Ana
    Kuna, Piotr
    Halken, Susanne
    Montagut, Armelle
    de Beaumont, Olivier
    Le Gall, Martine
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (01) : 160 - 166
  • [25] Treatment effect of grass-pollen immunotherapy for children with allergic rhinoconjunctivitis in a district general hospital
    Watson, P.
    Moltu, A.
    Dhesi, A.
    Dawson, T.
    ALLERGY, 2018, 73 : 506 - 506
  • [26] Relapse of allergic rhinoconjunctivitis after completion of 3 year course of grass pollen sublingual immunotherapy
    Grewal, Anjum
    Jay, Nicola
    CLINICAL AND EXPERIMENTAL ALLERGY, 2018, 48 (11): : 1557 - 1557
  • [27] Sublingual five-grass pollen tablets (Oralair®): A guide to their use as allergen immunotherapy for grass pollen-induced allergic rhinoconjunctivitis
    Lyseng-Williamson K.A.
    Drugs & Therapy Perspectives, 2014, 30 (6) : 200 - 208
  • [28] Beta glucuronidase short-term immunotherapy prevents seasonal rhinoconjunctivitis in grass pollen allergic patients by modifying dendritic cell phenotype
    Di Stanislao, C
    Angelini, F
    Gagliardi, MC
    Feccia, T
    Di Berardino, L
    Moschese, V
    Chini, L
    Polito, A
    Riccardi, C
    Rossi, P
    ALLERGY, 2002, 57 : 76 - 77
  • [29] Five-grass-pollen sublingual immunotherapy tablet for the treatment of grass-pollen-induced allergic rhinoconjunctivitis: 5 years of experience
    Didier, Alain
    Wahn, Ulrich
    Horak, Friedrich
    Cox, Linda S.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2014, 10 (10) : 1309 - 1324
  • [30] Detection of allergen-specific IgE in tears of grass pollen-allergic patients with allergic rhinoconjunctivitis
    HoffmannSommergruber, K
    Ferreira, FD
    Ebner, C
    Barisani, T
    Korninger, L
    Kraft, D
    Scheiner, O
    Baumgartner, I
    CLINICAL AND EXPERIMENTAL ALLERGY, 1996, 26 (01): : 79 - 87